Table 1 Clinical features related prognosis predictors of patients with GBS
From: Prognostic factors of Guillain-Barré syndrome: a 111-case retrospective review
Number of patients (%) | MRC score at discharge | Comparison* (P-value) | |
|---|---|---|---|
Type II Diabetes | 0.031* | ||
With | 5 (4.50%) | 22.4±11.8 | |
Without | 96 (95.50%) | 33.83±9.85 | |
High blood pressure | 0.034* | ||
With | 13 (11.71%) | 24.08±16.73 | |
Without | 98 (88.29) | 34.55±8.33 | |
GBS subtype | <0.001* | ||
AIDP | 67 (60.36%) | 31.45±10.877 | |
AMAN | 9 (8.11%) | 23.89±12.129 | |
MFS | 24 (21.62%) | 39.88±0.448 | |
CNV | 8 (7.21%) | 38.00±3.546 | |
BBE-GBS | 1 (0.90%) | 40.00±0.000 | |
GBS subtype | 0.032* | ||
AIDP | 67 (60.36%) | 31.45±10.877 | |
AMAN | 9 (8.11%) | 23.89±12.129 | |
GBS subtype | <0.001* | ||
AIDP | 67 (60.36%) | 31.45±10.877 | |
MFS | 24 (21.62%) | 39.88±0.448 | |
GBS subtype | 0.038* | ||
AIDP | 67 (60.36%) | 31.45±10.877 | |
CNV | 8 (7.21%) | 38.00±3.546 | |
GBS subtype | 0.209 | ||
AIDP | 67 (60.36%) | 31.45±10.877 | |
BBE-GBS | 1 (0.90%) | 40.00±0.000 | |
Preceding infection | 0.042* | ||
Upper respiratory tract infection | 39 (35.14%) | 35.82±8.003 | |
Diarrhea | 9 (8.11%) | 26.56±2.330 | |
Upper respiratory tract infection and diarrhea | 3 (2.70%) | 37.00±3.606 | |
Other virus | 4 (3.60%) | 37.25±4.856 | |
Other | 13 (11.72%) | 31.40±9.044 | |
Without | 43 (38.74%) | 30.80±11.96 | |
Preceding infection | 0.0016* | ||
Upper respiratory tract infection | 39 (35.14%) | 35.82±8.003 | |
without | 43 (38.74%) | 30.80±11.96 | |
Preceding infection | 0.217 | ||
Diarrhea | 9 (8.11%) | 26.56±2.330 | |
Without | 43 (38.74%) | 30.80±11.96 | |
Preceding infection | 0.552 | ||
Upper respiratory tract infection and diarrhea | 3 (2.70%) | 37.00±3.606 | |
Without | 43 (38.74%) | 30.80±11.96 | |
Preceding infection | 0.014* | ||
Upper respiratory tract infection | 39 (35.14%) | 35.82±8.003 | |
Diarrhea | 9 (8.11%) | 26.56±2.330 | |